For instance, the VHL gene in RCC could downregulate hypoxia-inducible factor (HIF)-1α and subsequently decrease vascular endothelial growth factor (VEGF) production, while VHL mutation in RCC could also enhance HLA-I expression and IFNα resistance (Perier et al., 2011). This evidence concerns the gene VEGFA and renal cell carcinoma.